Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments-Reference-Cited by-同舟云学术

Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments

Author:

Califf Robert M.¹,Hernandez Adrian F.²³,Landray Martin⁴

Affiliation:

1. Verily Life Sciences (Alphabet), South San Francisco, California

2. Duke Clinical Research Institute, Durham, North Carolina

3. Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina

4. Nuffield Department of Population Health, University of Oxford, Headington, Oxford, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

Reference10 articles.

2. Cognitive bias and public health policy during the COVID-19 pandemic.;Halpern;JAMA

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Ethical Problems of Observational Studies and Big Data Compared to Randomized Trials;The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine;2024-05-13